期刊文献+

203例孕妇羊水染色体检测结果分析 被引量:2

Analysis of the results of amniotic fluid chromosome detection among 203 pregnant women
下载PDF
导出
摘要 目的通过对孕妇孕中期羊水染色体检测结果的分析,探讨羊膜腔穿刺羊水染色体检查技术在产前诊断中的应用价值。方法对2013年6月-2017年12月间在河南省平顶山市妇幼保健院就诊的产前血清学筛查高风险孕妇、高龄孕妇(年龄35~42岁)、B超显示胎儿异常孕妇及因其他因素(如不良妊娠史、异常家族史等因素)需要进行产前诊断的孕妇,在孕18~24周进行羊膜腔穿刺羊水染色体检查,并对检查结果进行比对分析。结果 203例参加检测的羊水中,检出胎儿染色体异常22例,总检出率为10. 83%。其中产前筛查高危组的染色体畸变检出率为6. 12%、高龄孕妇组的染色体畸变检出率为8. 00%、B超异常组的染色体畸变检出率为37. 50%、其他组的染色体畸变检出率9. 67%。结论羊膜腔穿刺羊水染色体检查能检测胎儿的所有染色体数目异常和大片段的染色体结构异常,是目前胎儿染色体疾病产前诊断的"金标准"。 Objective To investigate the amniocentesis amniotic fluid chromosomal examination technique in prenatal diagnosis by analyzing the results of chromosomal detection of amniotic fluid in the second trimester of pregnancy.Methods From June 2013to December 2017,the pregnant women with high-risk prenatal serological screening,advanced age (aged between 35-42years old),Bdisplay abnormal fetal or other factors (such as adverse pregnancy history,abnormal family history,etc.)required prenatal diagnosis in our hospital.They were performed amniocentesis in amniotic fluid during 18-24weeks of pregnancy.The inspection results of them were analyzed.Results A total of 203cases of amniotic fluid participating in the test,fetal chromosomal abnormalities were detected in 22cases,the total detection rate was 10.83%.Among the results,the proportions of cases with high-risk prenatal serological screening were 6.12%(6/98),advanced age were 8%(4/50),B-display abnormal fetal were 37.5%(9/24),and other factors were 9.67%(3/31).Conclusion The abnormal chromosome number and chromosome structure with large segments of the fetus can be detected by amniocentesis of amniotic fluid.It is the "gold standard"for the prenatal diagnosis of fetal chromosome disease.
作者 沈雪 SHEN Xue(Maternal and Child Health Hospital of Pingdingshan City,Pingdingshan Henan,467000,China)
出处 《中国妇幼卫生杂志》 2018年第6期71-73,80,共4页 Chinese Journal of Women and Children Health
关键词 羊水 产前诊断 核型分析 结构异常 amniotic fluid prenatal diagnosis karyotyping structural abnormality
  • 相关文献

参考文献2

二级参考文献16

  • 1Shaw SW,Hsu JJ,Lee CN,et al.First-and secondtrimester Down syndrome screening:current strategies and clinical guidelines[J].Taiwan J Obstet Gynecol,2008,47(2):157-162.
  • 2Benn P,Wright D,Cuckle H.Practical strategies in contingent sequential screening for Down syndrome[J].Prenat Diagn,2005,25(8):645-652.
  • 3Wald N J,Watt HC,Hackshaw AK.Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters[J].N Engl J Med,1999,341(7):461-467.
  • 4Malone FD,Canick JA,Ball RH,et al.First-trimester or second-trimester screening,or both,for Down's syndrome[J].N Engl J Med,2005,353(19):2001-2011.
  • 5Chen Y,Qian X,Li J,et al.Cost-effectiveness analysis of prenatal diagnosis intervention for Down's syndrome in China[J].Int J Technol Assess Health Care,2007,23(1):138-145.
  • 6Chao AS,Chung CL,Wu CD,et al.Second trimester maternal serum screening using alpha fetoprotein,free beta human chorionic gonadotropin and maternal age specific risk:result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population[J].Acta Obstet Gynecol Scand,1999,78(5):393-397.
  • 7Jou HJ,Shyu MK,Chert SM,et al.Maternal serum screening for down syndrome by using alpba-fetoprotein and human chorionic gonadotropin in an asian population.a prospective study[J].Fetal Diagn Ther,2000,15 (2):108-111.
  • 8Kazerouni NN,Currier B,Maim L,et al.Triple-marker prenatal screening program for chromosomal defects[J].Obstet Gynecol,2009,114(1):50-58.
  • 9Reynolds TM,Aldis J.Median parameters for Down's syndrome screening should be calculated using a moving time-window method[J].Ann Clin Biochem,2008,45(Pt 6):567-570.
  • 10Solinas-Toido S,Lampel S,Stilgenbauer S,et al.Matrixbased comparative genomic hybridization:biochips to screen for genomic imbalances[J].Genes Chromosomes Cancer,1997,20(4):399-407.

共引文献26

同被引文献25

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部